Malignant tumor local infiltration inhibitor containing batroxobin

Details for Australian Patent Application No. 2005257487 (hide)

Owner Tobishi Pharmaceutical Co., Ltd.

Inventors Chang, Lishui; Wan, Yongling; Senga, Hirobumi

Agent Spruson & Ferguson

Pub. Number AU-A-2005257487

PCT Pub. Number WO2006/001502

Priority 2004-213636 24.06.04 JP

Filing date 24 June 2005

Wipo publication date 5 January 2006

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/001502 Priority application(s): WO2006/001502

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257496-Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists

2005257486-Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists